Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-07038124 ointment in atopic dermatitis and plaque psoriasis (Phase 2b)
jRCT2031220347Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2022
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of PF-07038124 in atopic dermatitis (AD) and plaque psoriasis (7 arms), sponsored by Pfizer. Started Nov 2022; status: completed.
02
Drugs
PF-07038124
03
Conditions
atopic dermatitis (AD)plaque psoriasis
Beyond the preview
Go deeper on jRCT2031220347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220347.